Characteristics of patients receiving non-curative chemotherapy
| First line (n=12) | Second line (n=8) | |
| Women | 5 | 3 |
| Men | 7 | 5 |
| Mean age (range), years | 63 (34–75) | 69 (64–75) |
| Marital status: | ||
| Married/cohabiting | 10 | 8 |
| Single | 1 | |
| Widow/widower | 1 | |
| Chemotherapy used | ||
| Fliri/bevacizumab | 10 | |
| FLOX (5-fluorouracil, folinic acid, oxaliplatin) | 1 | 8 |
| Capecitabine plus oxaliplatin (Xelox) | 1 |
All paticipants received 5-fluorouracil-based combination chemotherapy with irinotecan or oxaliplatin, ±bevacizumab.